Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Anxiety response pathway" does not refer to a single defined molecule, receptor, enzyme, transporter, or other canonical therapeutic target. Instead, it is an umbrella term describing complex networks of molecular cascades and signaling events in the brain that mediate behavioral and physiological responses to stress and contribute to anxiety-like behaviors. These include multiple interacting systems such as neurotransmitter receptors (GABAergic, serotonergic), kinases (e.g., Src kinase), intracellular second messengers (cAMP/PKA), immune/inflammatory mediators[2][3][1], metabolic processes related to oxidative stress[2], and epigenetic modifications affecting gene expression relevant for mood regulation[4]. Recent research has identified several key molecular nodes within these broader pathways that may serve as potential therapeutic targets. For example: Chronic stress can enhance Src kinase activity leading to downstream effects on synaptic proteins like Neuroligin 2 via MyosinVa interaction; pharmacological inhibition of Src reverses some anxiety-like behaviors in animal models by restoring inhibitory synaptic function.[1] Other studies highlight roles for cAMP/protein kinase A signaling in regulating amygdala-driven fear learning and emotional reactivity,[3] immune system involvement through neuroinflammation,[2] metabolic redox balance,[2] and epigenetic mechanisms such as histone acetylation/deacetylation influencing gene transcription relevant for stress adaptation.[4] Because "Anxiety response pathway" is not itself a discrete molecule or protein but rather encompasses many interconnected biological processes across different cell types and brain regions,[1][2][3][4] it cannot be classified under standard categories like receptor/enzyme/transporter/etc., nor does it have canonical abbreviations or aliases used in scientific literature. In summary: This entry is not suitable as a canonical drug target because it lacks specificity—it refers instead to broad biological processes involving many distinct molecules which themselves may be valid therapeutic targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anxiety response pathway.